期刊文献+

二肽基肽酶4通过ERK1/2信号通路促进人血管平滑肌细胞钙化 被引量:6

Dipeptidyl peptidase-4 promotes calcification of human vascular smooth muscle cells through ERK1/2 signaling pathway
原文传递
导出
摘要 目的探讨二肽基肽酶4(DPP4)在人血管平滑肌细胞(HVSMC)中的钙化作用及其机制。方法通过茜素红观察DPP-4对人血管平滑肌细胞(HVSMC)钙化的影响,并以Western印迹法检测细胞外信号调节激酶(ERK)1/2通路是否涉及DPP4诱导HVSMC相关钙化蛋白的表达。结果茜素红染色结果显示,DPP4组钙化结节较阴性对照组明显增多,与阳性对照组相当;且DPP4剂量和时间依赖性地促进钙化相关蛋白骨保护素(OPG)、骨桥蛋白(OPN)、Runt相关转录因子2(RUNX2)和骨形态发生蛋白2(BMP2)的表达。DPP4干预15rain明显刺激ERK1/2的磷酸化(P〈0.05),ERK1/2抑制剂可明显降低DPP4刺激的相关钙化蛋白表达(P〈0.05)。结论DPP4可能是通过ERK1/2信号通路促进HVSMC的钙化。 Objective To further investigate direct effects of dipeptidyl peptidase-4 (DPP4) on calcification and to identify responsible signaling pathways in human vascular smooth muscle cells ( HVSMC ). Methods The effect of DPP-4 on calcification of HVSMC was observed by alizarin red, and Western blot was used to detect whether DPP4 induced calcification-related protein expressions through extraeellular signal-regulated kinases 1/2 ( ERK1/2 ) pathway. Results The Alizarin red staining results showed that calcified nodules in DPP4 group were significantly increased as compared with control group, similar to calcification group. The protein expressions of osteoprotegerin (OPG), osteopontin (OPN), Runt-related transcription factor 2 (RUNX2), and bone morphogenetic protein 2 (BMP2) were stimulated by DPP4 in a concentration- and time-dependent manner. The phosphorylation level of ERK1/2 was significantly increased after DPP4 incubation for 15 rain ( P〈0.05 ). PD98059, an ERK1/2 inhibitor, significantly lowered DPP4-stimulated expressions of calcification-related proteins ( P 〈 0.05 ). Conclusion DPP4 may promote the calcification of HVSMC through ERK1/2 signaling pathways.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2017年第4期335-340,共6页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金项目(81270358)
关键词 二肽基肽酶4 血管平滑肌细胞 钙化 细胞外信号调节激酶1/2信号通路 Dipeptidyl peptidase 4 Vascular smooth muscle cells Calcification EHK1/2 signaling pathway
  • 相关文献

参考文献2

二级参考文献37

  • 1Chen NX, Moe SM. Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep, 2012, 14 : 228 - 237.
  • 2Foley RN, Collins AJ, Herzog CA, et al. Serum phosphorus levels associate with coronary atherosclerosis in young a- dults. J Am Soc Nephrol, 2009,20 : 397 -404.
  • 3Adeney KL, Siscovick DS, Ix JH, et al. Association of ser- um phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol, 2009,20 : 381 387.
  • 4Connolly GM, Cunningham R, McNamee PT, et a]. Elevatedserum phosphate predicts mortality in renal transplant recipi- ents. Transplantation, 2009,87 : 1040- 1044.
  • 5Ix JH, De Boer IH, Peralta CA, et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol, 2009,4 : 609 -615.
  • 6Eddington H, Hoefield R, Sinha S, et al. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol, 2010,5 : 2251 -2257.
  • 7Landray M J, Emberson JR, Blackwell L, et al. Prediction of ESRD and death among people with CKD : the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort stud- y. Am J Kidney Dis, 2010,56 : 1082 - 1094.
  • 8Chue CD, Edwards NC, Davis LJ, et al. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant, 2011,26 : 2576 - 2582.
  • 9Moore J, Tomson CR, Tessa Savage M, et al. Serum phos- phate and calcium concentrations are associated with reduced patient survival following kidney transplantation. Clin Trans- plant, 2011,25 : 406 -416.
  • 10Benavente D, Chue CD, Moore J, et al. Serum phosphate measured at 6 and 12 months after successful kidney trans- plant is independently associated with subsequent graft loss. Exp Clin Transplant, 2012,10 : 119 - 124.

共引文献32

同被引文献25

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部